Cargando…
In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA
Lipid Nanoparticles (LNPs) are a leading class of mRNA delivery systems. LNPs are made of an ionizable lipid, a polyethyleneglycol (PEG)-lipid conjugate and helper lipids. The success of LNPs is due to proprietary ionizable lipids and appropriate helper lipids. Using a benchmark lipid (D-Lin-MC3) we...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317807/ https://www.ncbi.nlm.nih.gov/pubmed/35889670 http://dx.doi.org/10.3390/nano12142446 |
_version_ | 1784755146707697664 |
---|---|
author | Medjmedj, Ayoub Ngalle-Loth, Albert Clemençon, Rudy Hamacek, Josef Pichon, Chantal Perche, Federico |
author_facet | Medjmedj, Ayoub Ngalle-Loth, Albert Clemençon, Rudy Hamacek, Josef Pichon, Chantal Perche, Federico |
author_sort | Medjmedj, Ayoub |
collection | PubMed |
description | Lipid Nanoparticles (LNPs) are a leading class of mRNA delivery systems. LNPs are made of an ionizable lipid, a polyethyleneglycol (PEG)-lipid conjugate and helper lipids. The success of LNPs is due to proprietary ionizable lipids and appropriate helper lipids. Using a benchmark lipid (D-Lin-MC3) we compared the ability of three helper lipids to transfect dendritic cells in cellulo and in vivo. Studies revealed that the choice of helper lipid does not influence the transfection efficiency of immortalized cells but, LNPs prepared with DOPE (dioleylphosphatidylethanolamine) and β-sitosterol were more efficient for mRNA transfection in murine dendritic cells than LNPs containing DSPC (distearoylphosphatidylcholine). This higher potency of DOPE and β-sitosterol LNPs for mRNA expression was also evident in vivo but only at low mRNA doses. Overall, these data provide valuable insight for the design of novel mRNA LNP vaccines. |
format | Online Article Text |
id | pubmed-9317807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93178072022-07-27 In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA Medjmedj, Ayoub Ngalle-Loth, Albert Clemençon, Rudy Hamacek, Josef Pichon, Chantal Perche, Federico Nanomaterials (Basel) Article Lipid Nanoparticles (LNPs) are a leading class of mRNA delivery systems. LNPs are made of an ionizable lipid, a polyethyleneglycol (PEG)-lipid conjugate and helper lipids. The success of LNPs is due to proprietary ionizable lipids and appropriate helper lipids. Using a benchmark lipid (D-Lin-MC3) we compared the ability of three helper lipids to transfect dendritic cells in cellulo and in vivo. Studies revealed that the choice of helper lipid does not influence the transfection efficiency of immortalized cells but, LNPs prepared with DOPE (dioleylphosphatidylethanolamine) and β-sitosterol were more efficient for mRNA transfection in murine dendritic cells than LNPs containing DSPC (distearoylphosphatidylcholine). This higher potency of DOPE and β-sitosterol LNPs for mRNA expression was also evident in vivo but only at low mRNA doses. Overall, these data provide valuable insight for the design of novel mRNA LNP vaccines. MDPI 2022-07-17 /pmc/articles/PMC9317807/ /pubmed/35889670 http://dx.doi.org/10.3390/nano12142446 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Medjmedj, Ayoub Ngalle-Loth, Albert Clemençon, Rudy Hamacek, Josef Pichon, Chantal Perche, Federico In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA |
title | In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA |
title_full | In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA |
title_fullStr | In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA |
title_full_unstemmed | In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA |
title_short | In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA |
title_sort | in cellulo and in vivo comparison of cholesterol, beta-sitosterol and dioleylphosphatidylethanolamine for lipid nanoparticle formulation of mrna |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317807/ https://www.ncbi.nlm.nih.gov/pubmed/35889670 http://dx.doi.org/10.3390/nano12142446 |
work_keys_str_mv | AT medjmedjayoub incelluloandinvivocomparisonofcholesterolbetasitosterolanddioleylphosphatidylethanolamineforlipidnanoparticleformulationofmrna AT ngallelothalbert incelluloandinvivocomparisonofcholesterolbetasitosterolanddioleylphosphatidylethanolamineforlipidnanoparticleformulationofmrna AT clemenconrudy incelluloandinvivocomparisonofcholesterolbetasitosterolanddioleylphosphatidylethanolamineforlipidnanoparticleformulationofmrna AT hamacekjosef incelluloandinvivocomparisonofcholesterolbetasitosterolanddioleylphosphatidylethanolamineforlipidnanoparticleformulationofmrna AT pichonchantal incelluloandinvivocomparisonofcholesterolbetasitosterolanddioleylphosphatidylethanolamineforlipidnanoparticleformulationofmrna AT perchefederico incelluloandinvivocomparisonofcholesterolbetasitosterolanddioleylphosphatidylethanolamineforlipidnanoparticleformulationofmrna |